Verastem (VSTM) Net Margin (2018 - 2026)
Verastem (VSTM) posted quarterly Net Margin of 238.1% for Q1 2026, down 1403.47% quarter-over-quarter from 18.27% in Q4 2025.
Analysis
Verastem (VSTM) Net Margin (2018 - 2026) Analysis & Trends
Verastem's Net Margin history runs 8 years deep, the most recent figure standing at 238.1% for Q1 2026.
- In Q1 2026, Net Margin changed N/A year-over-year to 238.1%; the TTM figure through Mar 2026 stood at 281.29% (changed N/A YoY), while the FY2025 annual figure was 535.3%, up 77122.0% from the prior year.
- Net Margin for Q1 2026 stood at 238.1%, down from 18.27% in the prior quarter.
- The five-year high for Net Margin was 18.27% in Q4 2025, with the low at 2524.61% in Q2 2025.
- The 4-year median for Net Margin is 315.97% (2026), against an average of 664.14%.
- The sharpest annual moves came in 2022 and 2025: Net Margin jumped 130151 bps in 2022, then plunged 234029 bps in 2025.
- Verastem's Net Margin stood at 662.21% in 2022, then jumped by 72 bps to 184.32% in 2024, then soared by 110 bps to 18.27% in 2025, then slumped by 1403 bps to 238.1% in 2026.
- Business Quant data shows VSTM's Net Margin at 238.1% in Q1 2026, 18.27% in Q4 2025, and 393.84% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 12.09% |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -3.12% |
| 10 | Verastem | 815.95 Mn | 679.59 Mn | 36.32 Mn | -86.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -86.51% |
| Mar 31, 2026 | -235.56% |
| Dec 31, 2025 | 18.27% |
| Sep 30, 2025 | -354.49% |
| Jun 30, 2025 | -1,213.57% |
| Jun 30, 2024 | -184.32% |
| Mar 31, 2022 | -654.47% |
| Dec 31, 2021 | -3,024.04% |
| Sep 30, 2021 | -1,139,300.00% |
| Jun 30, 2021 | -3,380.40% |
| Mar 31, 2021 | -1,494.14% |
| Dec 31, 2020 | -3,887.35% |
| Sep 30, 2020 | 16.71% |
| Jun 30, 2020 | -534.25% |
| Mar 31, 2020 | -751.38% |
| Dec 31, 2019 | -1,054.27% |
| Sep 30, 2019 | -333.69% |
| Jun 30, 2019 | -1,345.47% |
| Mar 31, 2019 | -2,280.19% |
| Dec 31, 2018 | -3,050.00% |